OCT 09, 2021 6:54 AM PDT

The Anti-Cancer, Copper-Binding Compounds Found in Fish

WRITTEN BY: Carmen Leitch

In the world's waterways, fish are confronted with endless challenges. For example, they have to defend themselves from predators, evade capture, compete with others for food, deal with the impact of pollution, and contend with a world of microbial life. Researcher and professor Myriam Cotten of The College of William & Mary has been studying fish immunity, and the small molecules that fish produce; in particular, compounds called piscidins that are generated by hybrid striped bass.

"There is a universal theme that organisms produce protective compounds that are co-evolving with the pathogens and the threats they are exposed to," said Cotten. Piscidins are thought to be a kind of host defense peptide (HDP).

Researcher and associate professor Alfredo Angeles-Boza of the University of Connecticut told Cotten that piscidins could bind to copper. Copper is known for its antimicrobial properties, producing the term 'contact killing,' and its use has to be carefully regulated in organisms because it can be toxic.

In this work, published in Scientific Reports, the scientists began engineering peptides that could link up with copper in vitro, and identified two that had efficacy against cancer cells.

HDPs already work against pathogens by disrupting cell membranes. "The peptides can form a helical structure, much like DNA also exists in a helical form. What happens with the binding is that you modify the structure," Cotten explained. "Now you have a disrupted helix, with a [flattened] structure as the head of the peptide and the rest of it actually remains a wrapped helix."

That disrupted helix happens to also be very good at attacking parts of the membranes of bacteria and cancer cells.

When HDPs are given an enhanced ability to bind to copper, they can destroy the cell membranes in a second way, with the copper, which can break bonds between molecules in the cell membranes.

Image credit: Pixabay

"When you bind the copper to the head of the peptide, you actually allow the head to get into the membrane," she said. "Instead of lying flat on the membrane it now gets deep inside the membrane." The cell membrane has to maintain its integrity, or the life of the cell is threatened.

These peptides aren't quite ready for clinical use because they don't yet leave healthy cells unharmed. But the researchers are hopeful that they can modify them so they can be applied in a targeted, direct way. "For instance, you have to use nanoscience to find a way to surround the peptide with a coating that will bring it to say, cancer cells over healthy cells," suggested Cotten.

Sources: The College of William & Mary, Scientific Reports

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
OCT 22, 2021
Genetics & Genomics
Studying the Evolution of SARS-CoV-2 in One Patient Over 324 Days
OCT 22, 2021
Studying the Evolution of SARS-CoV-2 in One Patient Over 324 Days
To clear a viral infection, the human body has to mount an effective immune response. After detecting the pathogen, immu ...
NOV 26, 2021
Coronavirus
Heavily Mutated COVID-19 B.1.1.529 Variant Emerges, WHO Names It Omicron
NOV 26, 2021
Heavily Mutated COVID-19 B.1.1.529 Variant Emerges, WHO Names It Omicron
On Thursday, November 2021, South African health officials announced that they had identified a new variant of the pande ...
DEC 02, 2021
Microbiology
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
DEC 02, 2021
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
Crimean-Congo hemorrhagic fever (CCHF) is a deadly disease, which is fatal in about 30 percent of cases. It's caused ...
DEC 03, 2021
Genetics & Genomics
Using CRISPR to Edit the Genomes of Microbes in the Gut
DEC 03, 2021
Using CRISPR to Edit the Genomes of Microbes in the Gut
The gene editing tool CRISPR was originally inspired by an immune defense system used by bacteria, and it's been adapted ...
Loading Comments...